Xbrane Biopharma AB (XBRANE) — Net Asset Momentum
Xbrane Biopharma AB (XBRANE) recorded a net asset momentum of 168.8% as of December 2025, with net assets of Skr560.65 Million SEK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Xbrane Biopharma AB fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Xbrane Biopharma AB Net Asset Momentum (2012–2025)
This chart tracks Xbrane Biopharma AB's year-over-year net asset growth across 14 annual reporting periods from 2012 to 2025. The most recent momentum reading is +168.8%, with net assets of Skr560.65 Million SEK as of December 2025. Read Xbrane Biopharma AB (XBRANE) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Xbrane Biopharma AB (2012–2025)
The table below shows the complete annual net asset history for Xbrane Biopharma AB from 2012 to 2025, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Xbrane Biopharma AB market capitalisation.
| Year | Net Assets (SEK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Skr560.65 Million | Skr671.62 Million | Skr110.97 Million | ▲ +168.8% |
| 2024 | Skr208.54 Million | Skr842.43 Million | Skr633.89 Million | ▲ +21.7% |
| 2023 | Skr171.34 Million | Skr653.51 Million | Skr482.17 Million | ▼ -59.7% |
| 2022 | Skr424.89 Million | Skr690.51 Million | Skr265.63 Million | ▼ -1.6% |
| 2021 | Skr431.74 Million | Skr688.43 Million | Skr256.69 Million | ▲ +67.5% |
| 2020 | Skr257.71 Million | Skr463.76 Million | Skr206.06 Million | ▲ +39.8% |
| 2019 | Skr184.32 Million | Skr338.94 Million | Skr154.62 Million | ▲ +121.9% |
| 2018 | Skr83.07 Million | Skr252.88 Million | Skr169.81 Million | ▼ -6.0% |
| 2017 | Skr88.41 Million | Skr110.96 Million | Skr22.55 Million | ▼ -17.6% |
| 2016 | Skr107.30 Million | Skr118.11 Million | Skr10.81 Million | ▲ +125.9% |
| 2015 | Skr47.51 Million | Skr75.33 Million | Skr27.82 Million | ▲ +654.4% |
| 2014 | Skr6.30 Million | Skr6.69 Million | Skr390.70K | ▼ -27.5% |
| 2013 | Skr8.69 Million | Skr9.20 Million | Skr505.44K | ▲ +9762.8% |
| 2012 | Skr88.11K | Skr657.01K | Skr568.90K | — |